全基因组关联研究揭示二尖瓣脱垂新遗传位点及多基因风险评分
AIMS: Mitral valve prolapse (MVP) is a common valvular heart disease with a prevalence of >2% in the general adult population.…
要点
- 荟萃分析鉴定出14个与二尖瓣脱垂相关的遗传位点。
- 候选基因包括TGF-β信号分子和血影蛋白β等。
- 首个MVP多基因风险评分可改善风险预测。
核心结论
- 研究鉴定出14个与二尖瓣脱垂相关的遗传位点,并展示了首个可用于风险分层的MVP多基因风险评分。
主要发现
- 主要分析鉴定出14个与MVP相关的位点,另在部分接受二尖瓣手术的样本中鉴定出2个额外位点。
- 整合表观遗传、转录和蛋白质组数据识别出候选MVP基因包括LMCD1、SPTBN1、LTBP2、TGFB2、NMB和ALPK3。
- 构建的MVP多基因风险评分在年龄、性别和临床危险因素之外改善了MVP风险预测。
关键数值与推荐
- MVP在普通成人人群中患病率>2%。
- 主要分析鉴定出14个与MVP相关的遗传位点。
临床怎么用
- MVP多基因风险评分最终可能有助于临床环境中对患者进行MVP筛查的风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Mitral valve prolapse (MVP) is a common valvular heart disease with a prevalence of >2% in the general adult population. Despite this high incidence, there is a limited understanding of the molecular mechanism of this disease, and no medical therapy is available for this disease. We aimed to elucidate the genetic basis of MVP in order to better understand this complex disorder. METHODS AND RESULTS: We performed a meta-analysis of six genome-wide association studies that included 4884 cases and 434 649 controls. We identified 14 loci associated with MVP in our primary analysis and 2 additional loci associated with a subset of the samples that additionally underwent mitral valve surgery. Integration of epigenetic, transcriptional, and proteomic data identified candidate MVP genes including LMCD1, SPTBN1, LTBP2, TGFB2, NMB, and ALPK3. We created a polygenic risk score (PRS) for MVP and showed an improved MVP risk prediction beyond age, sex, and clinical risk factors. CONCLUSION: We identified 14 genetic loci that are associated with MVP. Multiple analyses identified candidate genes including two transforming growth factor-β signalling molecules and spectrin β. We present the first PRS for MVP that could eventually aid risk stratification of patients for MVP screening in a clinical setting. These findings advance our understanding of this common valvular heart disease and may reveal novel therapeutic targets for intervention.
引用
- Roselli C, Yu M, Nauffal V, et al. Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse. Eur Heart J. 2022. PMID: 35245370. doi:10.1093/eurheartj/ehac049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。